🇺🇸 UTHR — United Therapeutics Corporation
Salud CompraPrecio actual
562,02 USD
Máx. histórico
608,49
2 días
Split 2:1 del 23/09/2009
Caída desde máximo
-7,64%
Rango 52 semanas
444,04 – 614,23
Variación hoy
-0,65%
Cierre anterior
565,72
Rango de hoy
559,41 – 569,45
Volumen hoy
454.934
Peor caída histórica
-93,18%
12/07/2000 → 10/12/2001
Recuperado en 3311 días
Volatilidad anualizada ⓘ
46,96%
- Nombre completo
- United Therapeutics Corporation
- Divisa
- USD
- Mercado
- NasdaqGS
- Sector
- Salud
- Industria
- Drug Manufacturers - Specialty & Generic
- Empleados
- 1.400
- PER ⓘ
- 21,22 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 670,93 USD (puede no estar actualizado)
- Primera cotización
- 17/06/1999
- Precio actualizado
- hace 6 horas
United Therapeutics Corporation engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. It offers Tyvaso DPI, an inhaled dry powder via pre-filled and single-use cartridges; Nebulized Tyvaso, an inhaled solution via ultrasonic nebulizer; Remodulin (treprostinil) injection to treat patients with pulmonary arterial hypertension to diminish symptoms associated with exercise; Orenitram, a tablet dosage form of treprostinil, to delay disease progression and improve exercise capacity in PAH patients; and Adcirca, an oral PDE-5 inhibitor to enhance the exercise ability in PAH patients. It also markets and sells Unituxin (dinutuximab) injection, a monoclonal antibody for high-risk neuroblastoma; and Remunity Pump, which contains a pump and separate controller for Remodulin. In addition, it is involved in developing RemunityPRO Pump and Ralinepag for the treatment of PAH;and Nebulized Tyvaso, for the treatment of idiopathic pulmonary fibrosis, as well as xenografts, which are development-stage organ products. Further, it provides preclinical products, including EVLP/CLES, for lung transplant; UKidney, UHeart, UThymoKidney, a development-stage gene-edited porcine kidneys and hearts for xenotransplantation; ULobe, for allogeneic regenerative medicine; ULung, for autologous regenerative medicine; IVIVA Kidney, for autologous regenerative medicine; miroliver, for allogeneic regenerative medicine; and mirokidney, for allogeneic regenerative medicine. It has licensing and collaboration agreements with DEKA Research & Development Corp. to develop a semi-disposable system for the subcutaneous delivery of treprostinil; MannKind Corporation to develop and license treprostinil inhalation powder and the Dreamboat device; and Arena Pharmaceuticals, Inc. to develop Ralinepag. The company was founded in 1996 and is headquartered in Silver Spring, Maryland.
| Fecha | Ratio |
|---|---|
| 23/09/2009 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 23/03/2011 | 65,00 | 65,49 | 64,38 | 65,15 | +0,08% | 1,71% | 429.900 |
| 22/03/2011 | 65,42 | 65,70 | 64,76 | 65,10 | -1,06% | 1,44% | 634.500 |
| 21/03/2011 | 66,71 | 67,57 | 65,65 | 65,80 | -0,27% | 2,88% | 584.100 |
| 18/03/2011 | 66,72 | 67,00 | 65,75 | 65,98 | +0,08% | 1,87% | 578.100 |
| 17/03/2011 | 65,98 | 66,27 | 65,46 | 65,93 | +0,90% | 1,23% | 326.200 |
| 16/03/2011 | 65,89 | 66,52 | 65,20 | 65,34 | -0,70% | 2,00% | 369.000 |
| 15/03/2011 | 65,17 | 66,20 | 64,60 | 65,80 | -0,99% | 2,46% | 443.100 |
| 14/03/2011 | 66,98 | 67,63 | 66,14 | 66,46 | -1,61% | 2,22% | 410.300 |
| 11/03/2011 | 66,75 | 67,72 | 66,50 | 67,55 | +0,81% | 1,83% | 350.600 |
| 10/03/2011 | 67,93 | 67,97 | 66,68 | 67,01 | -2,03% | 1,90% | 514.300 |
| 09/03/2011 | 68,46 | 69,54 | 68,32 | 68,40 | -0,42% | 1,78% | 424.900 |
| 08/03/2011 | 68,61 | 69,38 | 68,49 | 68,69 | -0,06% | 1,30% | 607.700 |
| 07/03/2011 | 70,02 | 70,34 | 68,03 | 68,73 | -1,16% | 3,30% | 469.000 |
| 04/03/2011 | 69,26 | 69,84 | 68,83 | 69,54 | +0,59% | 1,46% | 497.600 |
| 03/03/2011 | 68,41 | 69,87 | 68,41 | 69,13 | +1,44% | 2,13% | 583.400 |
| 02/03/2011 | 67,08 | 68,55 | 67,08 | 68,15 | +1,70% | 2,19% | 364.800 |
| 01/03/2011 | 67,18 | 67,54 | 66,63 | 67,01 | -0,62% | 1,35% | 453.000 |
| 28/02/2011 | 68,33 | 68,82 | 67,01 | 67,43 | -0,82% | 2,65% | 450.000 |
| 25/02/2011 | 67,57 | 68,06 | 67,10 | 67,99 | +1,28% | 1,42% | 423.200 |
| 24/02/2011 | 66,56 | 67,52 | 65,75 | 67,13 | +0,49% | 2,66% | 525.100 |
| 23/02/2011 | 66,75 | 67,40 | 65,78 | 66,80 | +0,45% | 2,43% | 731.500 |
| 22/02/2011 | 67,60 | 67,89 | 66,33 | 66,50 | -1,36% | 2,31% | 577.600 |
| 18/02/2011 | 68,02 | 68,14 | 67,18 | 67,42 | -0,58% | 1,41% | 271.700 |
| 17/02/2011 | 67,23 | 68,56 | 67,09 | 67,81 | +0,65% | 2,19% | 887.600 |
| 16/02/2011 | 67,13 | 68,97 | 66,60 | 67,37 | +0,52% | 3,53% | 1.348.600 |
| 15/02/2011 | 65,00 | 68,18 | 64,89 | 67,02 | -0,83% | 5,06% | 1.426.200 |
| 14/02/2011 | 67,61 | 68,51 | 67,36 | 67,58 | +0,46% | 1,70% | 517.300 |
| 11/02/2011 | 67,30 | 67,97 | 66,81 | 67,27 | -0,13% | 1,72% | 362.200 |
| 10/02/2011 | 65,99 | 67,80 | 65,80 | 67,36 | +1,91% | 3,03% | 478.100 |
| 09/02/2011 | 67,00 | 67,32 | 66,03 | 66,10 | -1,15% | 1,93% | 304.700 |